The mechanism of the late preconditioning effect of 3-nitropropionic acid

Arch Pharm Res. 2008 Oct;31(10):1257-63. doi: 10.1007/s12272-001-2104-3. Epub 2008 Oct 29.

Abstract

The aim of the present study was to investigate the mechanism of effect of 3-nitropropionic acid-(3-NP) induced late preconditioning in rat heart. For this purpose 20-30 min before 3-NP (20 mg/kg, i.p.) injection, the rats were treated intraperitoneally with 5-hydroxydecanoate (40 mg/kg, 5-HD, mitochondrial K(ATP)-channel blocker), L-NAME (100 mg/kg, NOS inhibitor), N-2-mercaptopropionylglycine (100 mg/kg, MPG, free radical scavenger), or superoxide dismutase+catalase (10000+10000 IU/kg, SOD+CAT). Control rats received saline only without 3-NP pretreatment. After two days, hearts were isolated and perfused at a constant pressure in a Langendorff apparatus. 15-min global ischemia followed by 30-min reperfusion was applied to all hearts. Pretreatment of 3-NP significantly reduced infarct size, creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH) levels, and incidence of ventricular tachycardia (VT) compared with the control group receiving saline only. 5-HD, L-NAME, MPG, or SOD+CAT treatment statistically reversed 3-NP-induced reduction in infarct size. Although CK-MB, LDH levels, and incidence of VT were also reduced by L-NAME, MPG, or SOD+CAT treatment, only 5-HD significantly inhibited beneficial effects of 3-NP on all of the parameters above. These results showed that mito-K(ATP) channels play a pivotal role in late preconditioning effect of 3-NP in the isolated rat heart. However, other mediators such as reactive oxygen species and NO may be, at least in part, involved in mechanisms of this effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / prevention & control
  • Creatine Kinase, MB Form / metabolism
  • Electrocardiography
  • Enzyme Inhibitors / pharmacology
  • Free Radical Scavengers / metabolism
  • Free Radicals / metabolism
  • In Vitro Techniques
  • Ischemic Preconditioning, Myocardial*
  • KATP Channels / agonists
  • KATP Channels / antagonists & inhibitors
  • L-Lactate Dehydrogenase / metabolism
  • Male
  • Myocardial Infarction / pathology
  • Myocardial Reperfusion Injury / pathology
  • Myocardial Reperfusion Injury / prevention & control
  • Myocardium / pathology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitro Compounds / pharmacology*
  • Potassium Channel Blockers / pharmacology
  • Propionates / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Free Radicals
  • KATP Channels
  • Nitro Compounds
  • Potassium Channel Blockers
  • Propionates
  • Nitric Oxide
  • L-Lactate Dehydrogenase
  • Nitric Oxide Synthase Type III
  • Creatine Kinase, MB Form
  • 3-nitropropionic acid
  • NG-Nitroarginine Methyl Ester